Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha
Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in art...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 1976-04, Vol.60 (4), p.556 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 556 |
container_title | The American journal of medicine |
container_volume | 60 |
creator | Weir, E K Greer, B E Smith, S C Silvers, G W Droegemueller, W Reeves, J T Grover, R F |
description | Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased. |
doi_str_mv | 10.1016/0002-9343(76)90723-3 |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_1274990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1274990</sourcerecordid><originalsourceid>FETCH-LOGICAL-p138t-918ba0f8d2187e28a1670d1c58aa87c6cb0c2eda6668bd695449dc3a8887e4493</originalsourceid><addsrcrecordid>eNo9T7tOwzAU9QAqpfAHIHmEweBH4tgjVC0gVWKBubqx3cYosS0nGfL3BKiYzlNHOgjdMPrAKJOPlFJOtCjEXSXvNa24IOIMLf_tC3TZ91-zpLqUC7RgvCq0pkvkn3MMpokmhn7I3gw-BgzB4jS2XQyQJ9xMyeXBhf4nsmP24Yihjvm36oMdjbO4njArSeeGZmpJyrEf4NjOOz7gLYc2NXCFzg_Q9u76hCv0ud18rF_J7v3lbf20I4kJNRDNVA30oCxnqnJcAZMVtcyUCkBVRpqaGu4sSClVbaUui0JbI0CpuT5zsUK3f7tprDtn9yn7br6xP10W33ZyWYY</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</creator><creatorcontrib>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</creatorcontrib><description>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</description><identifier>ISSN: 0002-9343</identifier><identifier>DOI: 10.1016/0002-9343(76)90723-3</identifier><identifier>PMID: 1274990</identifier><language>eng</language><publisher>United States</publisher><subject>Abortion, Induced - adverse effects ; Adolescent ; Adult ; Blood Cell Count ; Blood Pressure - drug effects ; Bronchial Diseases - blood ; Bronchial Diseases - chemically induced ; Bronchial Diseases - physiopathology ; Carbon Dioxide - blood ; Female ; Forced Expiratory Flow Rates ; Functional Residual Capacity ; Humans ; Hypertension, Pulmonary - blood ; Hypertension, Pulmonary - chemically induced ; Hypertension, Pulmonary - physiopathology ; Maximal Midexpiratory Flow Rate ; Oxygen - blood ; Pregnancy ; Pregnancy Trimester, Second ; Prostaglandins F - adverse effects ; Prostaglandins F - pharmacology ; Prostaglandins F - therapeutic use ; Pulmonary Diffusing Capacity ; Vital Capacity - drug effects</subject><ispartof>The American journal of medicine, 1976-04, Vol.60 (4), p.556</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1274990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weir, E K</creatorcontrib><creatorcontrib>Greer, B E</creatorcontrib><creatorcontrib>Smith, S C</creatorcontrib><creatorcontrib>Silvers, G W</creatorcontrib><creatorcontrib>Droegemueller, W</creatorcontrib><creatorcontrib>Reeves, J T</creatorcontrib><creatorcontrib>Grover, R F</creatorcontrib><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</description><subject>Abortion, Induced - adverse effects</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Blood Cell Count</subject><subject>Blood Pressure - drug effects</subject><subject>Bronchial Diseases - blood</subject><subject>Bronchial Diseases - chemically induced</subject><subject>Bronchial Diseases - physiopathology</subject><subject>Carbon Dioxide - blood</subject><subject>Female</subject><subject>Forced Expiratory Flow Rates</subject><subject>Functional Residual Capacity</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - blood</subject><subject>Hypertension, Pulmonary - chemically induced</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Maximal Midexpiratory Flow Rate</subject><subject>Oxygen - blood</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, Second</subject><subject>Prostaglandins F - adverse effects</subject><subject>Prostaglandins F - pharmacology</subject><subject>Prostaglandins F - therapeutic use</subject><subject>Pulmonary Diffusing Capacity</subject><subject>Vital Capacity - drug effects</subject><issn>0002-9343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T7tOwzAU9QAqpfAHIHmEweBH4tgjVC0gVWKBubqx3cYosS0nGfL3BKiYzlNHOgjdMPrAKJOPlFJOtCjEXSXvNa24IOIMLf_tC3TZ91-zpLqUC7RgvCq0pkvkn3MMpokmhn7I3gw-BgzB4jS2XQyQJ9xMyeXBhf4nsmP24Yihjvm36oMdjbO4njArSeeGZmpJyrEf4NjOOz7gLYc2NXCFzg_Q9u76hCv0ud18rF_J7v3lbf20I4kJNRDNVA30oCxnqnJcAZMVtcyUCkBVRpqaGu4sSClVbaUui0JbI0CpuT5zsUK3f7tprDtn9yn7br6xP10W33ZyWYY</recordid><startdate>197604</startdate><enddate>197604</enddate><creator>Weir, E K</creator><creator>Greer, B E</creator><creator>Smith, S C</creator><creator>Silvers, G W</creator><creator>Droegemueller, W</creator><creator>Reeves, J T</creator><creator>Grover, R F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>197604</creationdate><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><author>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p138t-918ba0f8d2187e28a1670d1c58aa87c6cb0c2eda6668bd695449dc3a8887e4493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Abortion, Induced - adverse effects</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Blood Cell Count</topic><topic>Blood Pressure - drug effects</topic><topic>Bronchial Diseases - blood</topic><topic>Bronchial Diseases - chemically induced</topic><topic>Bronchial Diseases - physiopathology</topic><topic>Carbon Dioxide - blood</topic><topic>Female</topic><topic>Forced Expiratory Flow Rates</topic><topic>Functional Residual Capacity</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - blood</topic><topic>Hypertension, Pulmonary - chemically induced</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Maximal Midexpiratory Flow Rate</topic><topic>Oxygen - blood</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, Second</topic><topic>Prostaglandins F - adverse effects</topic><topic>Prostaglandins F - pharmacology</topic><topic>Prostaglandins F - therapeutic use</topic><topic>Pulmonary Diffusing Capacity</topic><topic>Vital Capacity - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weir, E K</creatorcontrib><creatorcontrib>Greer, B E</creatorcontrib><creatorcontrib>Smith, S C</creatorcontrib><creatorcontrib>Silvers, G W</creatorcontrib><creatorcontrib>Droegemueller, W</creatorcontrib><creatorcontrib>Reeves, J T</creatorcontrib><creatorcontrib>Grover, R F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weir, E K</au><au>Greer, B E</au><au>Smith, S C</au><au>Silvers, G W</au><au>Droegemueller, W</au><au>Reeves, J T</au><au>Grover, R F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>1976-04</date><risdate>1976</risdate><volume>60</volume><issue>4</issue><spage>556</spage><pages>556-</pages><issn>0002-9343</issn><abstract>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</abstract><cop>United States</cop><pmid>1274990</pmid><doi>10.1016/0002-9343(76)90723-3</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 1976-04, Vol.60 (4), p.556 |
issn | 0002-9343 |
language | eng |
recordid | cdi_pubmed_primary_1274990 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Abortion, Induced - adverse effects Adolescent Adult Blood Cell Count Blood Pressure - drug effects Bronchial Diseases - blood Bronchial Diseases - chemically induced Bronchial Diseases - physiopathology Carbon Dioxide - blood Female Forced Expiratory Flow Rates Functional Residual Capacity Humans Hypertension, Pulmonary - blood Hypertension, Pulmonary - chemically induced Hypertension, Pulmonary - physiopathology Maximal Midexpiratory Flow Rate Oxygen - blood Pregnancy Pregnancy Trimester, Second Prostaglandins F - adverse effects Prostaglandins F - pharmacology Prostaglandins F - therapeutic use Pulmonary Diffusing Capacity Vital Capacity - drug effects |
title | Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A29%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchoconstriction%20and%20pulmonary%20hypertension%20during%20abortion%20induced%20by%2015-methyl-prostaglandin%20F2alpha&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Weir,%20E%20K&rft.date=1976-04&rft.volume=60&rft.issue=4&rft.spage=556&rft.pages=556-&rft.issn=0002-9343&rft_id=info:doi/10.1016/0002-9343(76)90723-3&rft_dat=%3Cpubmed%3E1274990%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1274990&rfr_iscdi=true |